OR WAIT null SECS
January 18, 2017
In a blog post, Robert Califf and Rita Nalubola discuss the agency’s approach to the use of genome-edited products.
January 11, 2017
The agency plans on publishing more than 100 new or revised guidance documents in 2017.
January 09, 2017
The partnership will focus on providing practical information to clients on the development of biologics and vaccines.
January 04, 2017
With a healthy supply of biosimilars heading to the approval pipeline, will license holders turn to contract manufacturers for development and production?
December 14, 2016
BMS changes its US geographic footprint with R&D investments and closures.
December 02, 2016
Biosimilars may be the key to CMO growth.
November 30, 2016
Takeda will invest more than 100 million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.
November 17, 2016
Avecia is adding drug substance capacity at its Milford, MA manufacturing site.
November 04, 2016
German biotech ARTES and Iranian biopharma manufacturer BioSun will develop an HPV vaccine.
November 02, 2016
Astellas will acquire Ganymed and its portfolio of ideal monoclonal antibody candidates.